Oscar Health (OSCR) Cash from Financing Activities (2020 - 2026)

Oscar Health has reported Cash from Financing Activities for 7 years, with the latest figure at -$3.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 173.88% year-over-year to -$3.6 million; the trailing twelve-month figure through Mar 2026 stood at $390.7 million (up 750.32% YoY), and the FY2025 full-year result was $399.2 million, up 483.74% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$3.6 million, down from $8.2 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $364.0 million in Q3 2025, with the low at -$3.6 million in Q1 2026.
• Historically, Cash from Financing Activities has averaged $45.4 million across 5 years, with a median of $3.8 million in 2024.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 5297.04% — and 2026, when it plunged 173.88%.
• Oscar Health's Cash from Financing Activities stood at $527000.0 in 2022, then surged by 102.85% to $1.1 million in 2023, then surged by 257.06% to $3.8 million in 2024, then soared by 114.07% to $8.2 million in 2025, then plunged by 144.06% to -$3.6 million in 2026.
• The last three Cash from Financing Activities figures came in at -$3.6 million (Q1 2026), $8.2 million (Q4 2025), and $364.0 million (Q3 2025), per Business Quant data.